Outcomes after radiotherapy for basaloid squamous cell carcinoma of the head and neck: A case-control study

Cancer

Volumn 112, Issue 12, 2008, Pages 2698-2709

  Thariat, Juliette ^a   Ahamad, Anesa ^a   El Naggar, Adel K ^a   Williams, Michelle D ^a   Holsinger, Floyd C ^a   Glisson, Bonnie S ^a   Allen, Pamela K ^a   Morrison, William H ^a   Weber, Randal S ^a   Ang, K Kian ^a   Garden, Adam S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Basaloid; Case control study; Head and neck; Neck dissection; Radiotherapy; Review; Squamous cell carcinoma

Indexed keywords

CARBOPLATIN; CISPLATIN; TAXANE DERIVATIVE;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CASE CONTROL STUDY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CONTROL; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; HEAD AND NECK TUMOR; LYMPH NODE METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RADIATION DOSE; SURVIVAL RATE; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, BASOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY DOSAGE; SURVIVAL RATE;

EID: 46049104966     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23486     Document Type: Article

References (35)

1. Wain SL, Kier R, Vollmer RT, Bossen EH. Basaloid-squamous Carcinoma of the tongue, hypopharynx, and larynx: report of 10 cases. Hum Pathol. 1986;17:1158-1166.
2. Winzenburg SM, Niehans GA, George E, Daly K, Adams GL. Basaloid squamous carcinoma: a clinical comparison of 2 histologic types with poorly differentiated squamous cell carcinoma. Otolaryngol Head Neck Surg. 1998;119:471-475.
3. Barnes L, Ferlito A, Altavilla G, MacMillan C, Rinaldo A, Doglioni C. Basaloid squamous cell carcinoma of the head and neck: clinicopathological features and differential diagnosis. Ann Otol Rhinol Laryngol. 1996;105:75-82.
4. Stelow EB, Mills SE. Squamous cell carcinoma variants of the upper aerodigestive tract. Am J Clin Pathol. 2005; 124(suppl):S96-S109.
5. Banks ER, Frierson HF Jr, Mills SE, George E, Zarbo RJ, Swanson PE. Basaloid squamous cell carcinoma of the head and neck. A clinicopathologic and immunohistochemical study of 40 cases. Am J Surg Pathol. 1992;16:939-946.
6. Kleist B, Bankau A, Lorenz G, Jager B, Poetsch M. Different risk factors in basaloid and common squamous head and neck cancer. Laryngoscope. 2004;114:1063-1068.
7. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and 2 variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000;48:7-16.
8. Ang KK, Garden AS. Radiotherapy for Head and Neck Cancers: Indications and Techniques, 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2005.
9. Greene FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Manual, 6th ed. New York, NY: Springer-Verlag; 2002.
10. Altavilla G, Mannara GM, Rinaldo A, Ferlito A. Basaloid squamous cell carcinoma of oral cavity and oropharynx. ORL J Otorhinolaryngol Relat Spec. 1999;61:169-173.
11. Bahar G, Feinmesser R, Popovtzer A, et al. Basaloid squamous carcinoma of the larynx. Am J Otolaryngol. 2003;24: 204-208.
12. Bracero F, Gamiz MJ, Soldado L, et al. [Hypopharynx and larynx basaloid squamous carcinoma: our experience with 6 cases.] Acta Otorrinolaringol Esp. 2001;52:229-236.
13. Coppola D, Catalano E, Tang CK, Elfenbein IB, Harwick R, Mohr R. Basaloid squamous cell carcinoma of floor of mouth. Cancer. 1993;72:2299-2305.
14. Sampaio-Goes FC, Oliveira DT, Dorta RG, et al. Expression of PCNA, p53, Bax, and Bcl-X in oral poorly differentiated and basaloid squamous cell carcinoma: relationships with prognosis. Head Neck. 2005;27:982-989.
15. Erdamar B, Suoglu Y, Sirin M, Karatay C, Katircioglu S, Kiyak E. Basaloid squamous cell carcinoma of the supraglottic larynx. Eur Arch Otorhinolaryngol. 2000;257:154-157.
16. Ereno C, Lopez JI, Sanchez JM, Toledo JD. Basaloid-squamous cell carcinoma of the larynx and hypopharynx. A clinicopathologic study of 7 cases. Pathol Res Pract. 1994;190:186-193.
17. Erisen LM, Coskun H, Ozuysal S, et al. Basaloid squamous cell carcinoma of the larynx: a report of 4 new cases. Laryngoscope. 2004;114:1179-1183.
18. Ferlito A, Altavilla G, Rinaldo A, Doglioni C. Basaloid squamous cell carcinoma of the larynx and hypopharynx. Ann Otol Rhinol Laryngol. 1997;106:1024-1035.
19. Klijanienko J, el-Naggar A, Ponzio-Prion A, Marandas P, Micheau C, Caillaud JM. Basaloid squamous carcinoma of the head and neck. Immunohistochemical comparison with adenoid cystic carcinoma and squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1993;119:887-890.
20. Larner JM, Malcolm RH, Mills SE, Frierson HF Jr, Banks ER, Levine PA. Radiotherapy for basaloid squamous cell carcinoma of the head and neck. Head Neck. 1993;15:249-252.
21. Luna MA, el Naggar A, Parichatikanond P, Weber RS, Batsakis JG. Basaloid squamous carcinoma of the upper aerodigestive tract. Clinicopathologic and DNA flow cytometric analysis. Cancer. 1990;66:537-542.
22. Marioni G, Gaio E, Giacomelli L, et al. Endoglin (CD105) expression in head and neck basaloid squamous cell carcinoma. Acta Otolaryngol. 2005;125:307-311.
23. Paulino AF, Singh B, Shah JP, Huvos AG. Basaloid squamous cell carcinoma of the head and neck. Laryngoscope. 2000;110:1479-1482.
24. Raslan WF, Barnes L, Krause JR, Contis L, Killeen R, Kapadia SB. Basaloid squamous cell carcinoma of the head and neck: a clinicopathologic and flow cytometric study of 10 new cases with review of the English literature. Am J Otolaryngol. 1994;15:204-211.
25. Soriano E, Righini C, Faure C, et al. [Course and prognosis of basaloid squamous cell carcinoma: case-control study of 49 patients.] Ann Otolaryngol Chir Cervicofac. 2005;122:173-180.
26. Wieneke JA, Thompson LD, Wenig BM. Basaloid squamous cell carcinoma of the sinonasal tract. Cancer. 1999;85:841-854.
27. Zbaren P, Nuyens M, Stauffer E. Basaloid squamous cell carcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg. 2004;12:116-121.
28. Cabanillas R, Rodrigo JP, Ferlito A, et al. Is there an epidemiological link between human papillomavirus DNA and basaloid squamous cell carcinoma of the pharynx? Oral Oncol. 2007;43:327-332.
29. Rodriguez Tojo MJ, Garcia Cano FJ, Infante Sanchez JC, Velazquez Fernandez E, Aguirre Urizar JM. Immunoexpression of p53, Ki-67 and E-cadherin in basaloid squamous cell carcinoma of the larynx. Clin Transl Oncol. 2005;7:110-114.
30. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer. 2001;92:805-813.
31. Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck-Wikland E. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer. 2000;89:300-304.
32. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709-720.
33. Salerno G, Di Vizio D, Staibano S, et al. Prognostic value of p27Kip1 expression in basaloid squamous cell carcinoma of the larynx. BMC Cancer [serial online]. 2006;6:146.
34. Poetsch M, Lorenz G, Bankau A, Kleist B. Basaloid in contrast to nonbasaloid head and neck squamous cell carcinomas display aberrations especially in cell cycle control genes. Head Neck. 2003;25:904-910.
35. Choi HR, Roberts DB, Johnigan RH, et al. Molecular and clinicopathologic comparisons of head and neck squamous carcinoma variants: common and distinctive features of biological significance. Am J Surg Pathol. 2004;28:1299-1310.